Anavex Life Sciences Corp.
AVXL
Revenue
0.00
0.000.00%
-Assets
132.99M
▲29.17M▲28.10%
3 Months ChangeLiabilities
6.37M
▼-2.58M▼-28.78%
3 Months ChangeFree Cash Flow
-2.66M
▼-2.66M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-25
Form 8-K
ID: 0001731122-26-000305
2026-02-09
Form 10-Q
ID: 0001731122-26-000200
2026-02-09
Form 8-K
ID: 0001731122-26-000193
2025-11-25
Form 8-K
ID: 0001731122-25-001591
2025-11-14
Form 8-K
ID: 0001731122-25-001536
2025-08-12
Form 10-Q
ID: 0001731122-25-001105
2025-07-28
Form 8-K
ID: 0001731122-25-001033
2025-07-03
Form 8-K
ID: 0001731122-25-000935
2025-06-13
Form 8-K
ID: 0001731122-25-000878
2025-05-13
Form 10-Q
ID: 0001731122-25-000724